NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Completed · Phase 4

Conditions studied: Erosive Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease

In brief

The purpose of this study is to decide if controlling stomach acid is related to healing of erosive esophagitis after treatment with esomeprazole magnesium (NEXIUM®) 10 mg and 40 mg once daily.

Key facts

Study ID
NCT00206180
Run by
AstraZeneca
People needed
120
Starts
2004-06-01
Expected to finish
2005-08-01
Last updated by the study team
2009-03-26

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.